North America Non-Surgical Bio-Implants Market was valued at USD 0.80 Billion in 2022 and is projected to reach USD 1.70 Billion by 2030, growing at a CAGR of 10.0% from 2024 to 2030.
The North American non-surgical bio-implants market is experiencing significant growth, driven by technological advancements and an increasing demand for minimally invasive procedures. These implants, which include materials like collagen, hyaluronic acid, and biopolymers, are utilized across various medical fields, including orthopedics, dentistry, and ophthalmology. The market's expansion is attributed to factors such as a rising geriatric population, increased healthcare awareness, and a preference for non-invasive treatments. For instance, the market size was valued at USD 142.63 billion in 2023 and is projected to reach USD 296.13 billion by 2030, growing at a CAGR of 11% from 2024 to 2030. citeturn0search2
Industries are increasingly adopting non-surgical bio-implants due to their advantages over traditional surgical methods. These benefits include reduced recovery times, lower risk of infection, and minimal scarring. The versatility of these implants allows for their application in various medical procedures, enhancing their appeal to both healthcare providers and patients. The demand for non-surgical bio-implants is expected to continue rising, with the market projected to grow at a CAGR of 7.9% from USD 45.3 billion in 2023 to USD 89.2 billion by 2032. citeturn0search3
In the United States, the market is expected to achieve a value of $59,597.4 million by 2031, maintaining its dominance in the region. Canada and Mexico are also experiencing growth, with projected CAGRs of 9.8% and 8.8%, respectively, during the forecast period from 2024 to 2031. citeturn0search4
Healthcare providers are increasingly incorporating non-surgical bio-implants into their treatment offerings to meet the growing demand for minimally invasive procedures. This trend is expected to continue, with the market projected to grow at a CAGR of 13.2% from 2022 to 2032, reaching USD 96 billion by 2032. citeturn0search8
Overall, the North American non-surgical bio-implants market is poised for substantial growth, driven by technological advancements, a preference for minimally invasive procedures, and increasing applications across various medical fields. The market's expansion presents significant opportunities for healthcare providers and manufacturers to meet the evolving needs of patients seeking effective and less invasive treatment options.
North America Non-Surgical Bio-Implants Market
Get an In-Depth Research Analysis of the North America Non-Surgical Bio-Implants Market Size And Forecast [2025-2032]
Albiorex International
FibroGen
Kythera Pharmaceuticals
Moma Therapeutics
Novatex Bioengineering SA
Anika Therapeutics
Johnson & Johnson
Fidia Farmaceutici
LCA Pharma
Hangzhou Gallop Biological
Albiorex International
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the North America Non-Surgical Bio-Implants Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the North America Non-Surgical Bio-Implants Market
Hospitals
Clinics
Ambulatory Surgical Centers
Academic and Research Center
Others
Based on Types the Market is categorized into Below types that held the largest Non-Surgical Bio-Implants market share In 2023.
Collagen
Hyaluronic Acid
Biopolymer
Hydrogels
Hydroxyapatite
Others
North America (United States, North America and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Non-Surgical Bio-Implants Market Research Analysis
1. Introduction of the North America Non-Surgical Bio-Implants Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. North America Non-Surgical Bio-Implants Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. North America Non-Surgical Bio-Implants Market, By Type
6. North America Non-Surgical Bio-Implants Market, By Application
7. North America Non-Surgical Bio-Implants Market, By Geography
North America
Europe
Asia Pacific
Rest of the World
8. North America Non-Surgical Bio-Implants Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading North America Research and Consulting firm servicing over 5000+ North America clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/